GfV Statement on the Federal Government's Centralized and Exclusive Procurement of the Pfizer/BioNTech COVID-19 Vaccine from 2024 to 2026
AWMF S2k guideline "Guideline for the prophylaxis of severe illnesses caused by respiratory syncytial virus (RSV) in children at risk"

Latest comments